Table 3.

Difference in dependent variables between four groups after treatment

Variables	non-CTS Control	non-CTS Linalool	CTS Control	CTS Linalool	P-valuea
sBP
Pre-test	125.00 ± 10.49	120.00 ± 9.61	130.00 ± 8.94	124.55 ± 15.08
Post-test	121.67 ± 9.83	117.14 ± 10.69	128.33 ± 9.83	114.55 ± 16.95
Difference	3.33 ± 13.66	2.86 ± 10.69	1.67 ± 17.22	10.00 ± 8.94	0.237
P-valueb	0.576	0.336	0.822	0.004
dBP
Pre-test	78.33 ± 7.53	74.29 ± 7.56	79.67 ± 5.72	79.09 ± 5.39
Post-test	81.67 ± 9.83	72.14 ± 8.93	78.33 ± 9.83	73.64 ± 9.24
Difference	−3.33 ± 5.16	2.14 ± 8.02	1.33 ± 11.08	5.45 ± 6.88	0.192
P-valueb	0.175	0.336	0.780	0.025
Pulse rate
Pre-test	71.50 ± 8.71	75.00 ± 8.38	86.67 ± 12.75	70.36 ± 10.61
Post-test	69.83 ± 4.83	71.36 ± 7.98	85.33 ± 11.64	65.55 ± 8.80
Difference	1.67 ± 6.22	3.64 ± 0.97	1.33 ± 5.32	4.82 ± 5.60	0.435
P-valueb	0.540	0.004	0.566	0.017

Data presented as mean ± standard deviation

T-VAS tingling visual analogue scale, sBP systolic blood pressure, dBP diastolic blood pressure, CTS carpal tunnel syndrome

^aDifferences among groups analyzed using the Kruskal-Wallis test

^bWithin group differences analyzed using Wilcoxon’s rank-sum test